Gastric lavage malignant cells (yGL) and hypohemoglobinemia (yAnemia) as new systems of tumor regression grading and prognostic prediction for gastric cancer …

E Virgilio, E Giarnieri, MR Giovagnoli… - Anticancer …, 2019 - ar.iiarjournals.org
Background/Aim: Although reckoned necessary for survival benefit, neoadjuvant
chemotherapy (NAC) of gastric cancer (GC) patients has so far provided questionable …

Neutrophil–lymphocyte Ratio and Histological Response Correlate With Prognosis of Gastric Cancer Undergoing Neoadjuvant Chemotherapy

N Urakawa, S Kanaji, T Kato, R Sawada, H Harada… - in vivo, 2023 - iv.iiarjournals.org
Abstract Background/Aim: Neoadjuvant chemotherapy (NAC) for advanced gastric cancer
(GC) and esophagogastric junction cancer (EGC) is expected to effectively control the tumor; …

[HTML][HTML] Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients

HL Zheng, J Lu, JW Xie, JB Wang, JX Lin, QY Chen… - BMC cancer, 2019 - Springer
Background The platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR),
and neutrophil to lymphocyte ratio (NLR) reflect the systematic inflammatory response, with …

[HTML][HTML] Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy

H Jin, G Zhang, X Liu, X Liu, C Chen, H Yu… - World journal of surgical …, 2013 - Springer
Background Accurate predictors of survival for patients with advanced gastric cancer treated
with neoadjuvant chemotherapy are currently lacking. In this study, we aimed to evaluate the …

[HTML][HTML] The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers

YL Wang, XX Ge, Y Wang, MD Xu, FR Gong, M Tao… - BMC …, 2018 - Springer
Background The classifications and counts of white blood cells (WBCs) have been proved to
be able to be used as prognostic markers in cancer cases. The present study investigated …

[HTML][HTML] The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 …

Z Li, S Li, X Ying, L Zhang, F Shan, Y Jia, J Ji - Gastric Cancer, 2020 - Springer
Background The clinical values of inflammatory and nutritional markers remained unclear for
gastric cancer with neoadjuvant chemotherapy (NACT). Methods The inflammatory …

[HTML][HTML] Decrease in blood neutrophil-to-lymphocyte ratio indicates better survival after neoadjuvant chemotherapy in patients with advanced gastric cancer

Z Liu, Y Liang, X Tang, H Qu - Frontiers in surgery, 2021 - frontiersin.org
Introduction: Gastric cancer is the fifth most commonly diagnosed tumor and is the fourth
leading cause of cancer-related mortality, worldwide. Due to the low rate of early diagnosis …

[HTML][HTML] Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer

C Hu, Y Zhang, J Xu, W Chen, P Yu… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Neoadjuvant chemotherapy (NCT) was developed to improve the prognosis of
patients with advanced gastric cancer (AGC). Some studies have confirmed the diagnostic …

Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent …

E Virgilio, E Giarnieri, MR Giovagnoli… - …, 2018 - Wiley Online Library
Objective As of 2017, the pathobiology of gastric cancer (GC) is far from fully understood;
consequently, new methods of basic and advanced research have been proposed and …

[HTML][HTML] The prognostic roles of red blood cell-associated indicators in patients with resectable gastric cancers

MT Cui, ZW Liang, YZ Sun, J Wu, H Lu… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background Gastric cancer (GC) is one of the leading causes of cancer-related death
worldwide. This study was designed to investigate the prognostic values of red blood cell …